# Faeth Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: 10-K/A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 16:18 ET
- Period: 2022-12-31
- Accession: 0000950170-23-016251
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000095017023016251/snse-20221231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000095017023016251/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000095017023016251/snse-20221231.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-016251. Last ingested by Listed: Nov 3, 2026, 23:17 ET. No prices; not investment advice.